Literature DB >> 1580790

The closed chamber technique--uptake, endogenous production, excretion, steady-state kinetics and rates of metabolism of gases and vapors.

J G Filser1.   

Abstract

The "closed chamber technique" (CCT) is presented. It allows investigation of pharmacokinetics of volatile substances in vivo in animals and in man and in vitro using tissue fractions. During the exposure period only the atmospheric concentrations of the substance are measured. The concentration-time data obtained are pharmacokinetically analyzed by a two compartment model describing uptake, endogenous production and excretion of the unchanged substance and its metabolic elimination. Using this model, pharmacokinetics of ethylene have been determined in rats and man. For both species, the results compared well with an estimation based on an allometric species scaling. Furthermore, the applicability of CCT is demonstrated in vivo on several other gases and vapors of solvents, e.g. trichloroethylene and 1,1,1-trichloroethane, and in vitro on 1,2-epoxybutene-3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580790     DOI: 10.1007/bf02307263

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  57 in total

1.  Pharmacokinetics of trichloroethylene in volunteers, influence of workload and exposure concentration.

Authors:  A C Monster; G Boersma; W C Duba
Journal:  Int Arch Occup Environ Health       Date:  1976-12-15       Impact factor: 3.015

2.  Metabolism of ethane and pentane to carbon dioxide by the rat.

Authors:  M S Daugherty; T M Ludden; R F Burk
Journal:  Drug Metab Dispos       Date:  1988 Sep-Oct       Impact factor: 3.922

3.  Pharmacokinetics of propylene and its reactive metabolite propylene oxide in Sprague-Dawley rats.

Authors:  K Golka; H Peter; B Denk; J G Filser
Journal:  Arch Toxicol Suppl       Date:  1989

4.  Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide.

Authors:  L Ehrenberg; K D Hiesche; S Osterman-Golkar; I Wenneberg
Journal:  Mutat Res       Date:  1974-08       Impact factor: 2.433

5.  Experimental pharmacokinetics and toxicology of acrylonitrile.

Authors:  H Peter; H M Bolt
Journal:  G Ital Med Lav       Date:  1984 May-Jul

6.  Pharmacokinetics of halogenated ethylenes in rats.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1979-06-08       Impact factor: 5.153

7.  Absence of lipid peroxidation as determined by ethane exhalation in rats treated with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  L W Robertson; U Regel; J G Filser; F Oesch
Journal:  Arch Toxicol       Date:  1985-04       Impact factor: 5.153

8.  Inhalation pharmacokinetics based on gas uptake studies. I. Improvement of kinetic models.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1981-07       Impact factor: 5.153

9.  Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics.

Authors:  R Kreiling; R J Laib; J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

10.  Pharmacokinetics of vinyl chloride in the rat.

Authors:  H M Bolt; R J Laib; H Kappus; A Buchter
Journal:  Toxicology       Date:  1977-04       Impact factor: 4.221

View more
  14 in total

1.  Statistical analysis of toxicokinetic data by nonlinear regression (example: inhalation pharmacokinetics of propylene)

Authors:  M Becka; H M Bolt; W Urfer
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

2.  Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation.

Authors:  G Johanson; J G Filser
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

3.  Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats.

Authors:  R J Laib; M Tucholski; J G Filser; G A Csanády
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

4.  Global optimization of the Michaelis-Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats.

Authors:  Marina V Evans; Christopher R Eklund; David N Williams; Yusupha M Sey; Jane Ellen Simmons
Journal:  Inhal Toxicol       Date:  2020-04-02       Impact factor: 2.724

5.  Statistical analysis of toxicokinetic data by nonlinear regression.

Authors:  G A Csanády; J G Filser
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

6.  Dose-DNA adduct relationship for ethylene oxide.

Authors:  H M Bolt; M Leutbecher
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.

Authors:  G Johanson; J G Filser
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

8.  New scientific arguments for regulation of ethylene oxide residues in skin-care products.

Authors:  J G Filser; P E Kreuzer; H Greim; H M Bolt
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man.

Authors:  G A Csanády; A L Mendrala; R J Nolan; J G Filser
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Pharmacokinetics of ethylene in man; body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene.

Authors:  J G Filser; B Denk; M Törnqvist; W Kessler; L Ehrenberg
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.